press center press release

BioShares ETFs to Ring The Nasdaq Stock Market Opening Bell




BioShares ETFs, will visit the Nasdaq MarketSite in Times Square to celebrate their listing of two exchange-traded funds (ETFs).

The BioSharesTM Biotechnology Clinical Trials Fund (Nasdaq:BBC) and the BioSharesTM Biotechnology Products Fund (Nasdaq:BBP), began trading on The Nasdaq Stock Market on December 17, 2014. BBC is a fund that seeks to track an index of biotechnology companies with a principal focus on running human clinical trials. BBP is a fund that seeks to track an index of biotechnology companies with one or more drugs approved by the FDA and in commercial production. Both funds employ an equal weighting approach that allows each security’s performance to affect the ETF equally, regardless of the size of the company.

In honor of the occasion, Paul Yook, Co-Founder of LifeSci Index Partners and Andrew MacDonald, Ph.D, Chief Executive Officer of LifeSci Index Partners will ring the Opening Bell.


Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio


Wednesday, March 4, 2015 – 9:15 a.m. to 9:30 a.m. ET

BioShares ETFs Media Contact:

Arro Financial Communications

Alexandra Levis

(305) 753-0238

Nasdaq MarketSite:

Alexa Sugrue

(212) 231-5552

Christine Barna

(646) 441-5310

Feed Information:

Fiber Line (Encompass Waterfront): 4463

Gal 3C/06C 95.05 degrees West

18 mhz Lower

DL 3811 Vertical

FEC 3/4

SR 13.235

DR 18.295411

MOD 4:2:0


Social Media:

For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies please visit our Facebook page at:

For photos from ceremonies and events visit our Instagram Page:

For news tweets, please visit our Twitter page at:

For exciting viral content and ceremony photos visit Tumblr Page:


A webcast of the Nasdaq Opening Bell will be available at: or


To obtain a hi-resolution photograph of the Market Open, please go to and click on the market open of your choice.

About LifeSci Index Partners, LLC:

LifeSci Index Partners, LLC is an index provider of biotechnology-focused stock market indices and also serves as the investment sub-advisor for the BioShares exchange traded funds. The principals of our firm are also founders of and/or are affiliated with LifeSci Advisors, LLC, a unique investor relations consultancy founded to provided companies in the life sciences a comprehensive solution to investor communications and outreach. Etfis Capital LLC serves as the investment adviser and LifeSci Index Partners, LLC serves as the sub-adviser to BioShares ETFs. BioShares ETFs are distributed by ETF Distributors LLC, an affiliate of Etfis Capital LLC. For more information, please visit

About Nasdaq’s ETP Listings Business:

Nasdaq operates an efficient platform for successfully introducing a product suite into one of the single largest pools of liquidity, including market participants which represent a full spectrum of investors. ETF issuers benefit from an end-to-end solution that provides ongoing product support including index licensing, listings opportunities, data offerings and trading services. As the home to some of the world’s most innovative ventures, Nasdaq generates opportunities for issuers to access new markets and deliver new concepts that change the way the industry develops, manages and applies ETFs.

About Nasdaq:

Nasdaq (Nasdaq:NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,500 listed companies with a market value of over $9.1 trillion and more than 10,000 corporate clients. To learn more, visit or


In This Story


Nasdaq Press Center

Read the latest press releases, request a press kit, and get in touch with our press team.

learn more